RxDoctor Payments Data

Nicole Stephens, PA

Physician Assistant · Durham, NCNPI 1801293667

Payments from drug & device makers

$297in general payments, 2019–2025

Across 13 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$81
  • Medtronic$68
  • Boston Scientific$55
  • E.r. Squibb & Sons, L.L.C.$32
  • AstraZeneca$29
  • Sanofi-aventis U.S. LLC$18
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$27091%
  • Education$279%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$297 in reported general payments places this provider in the 50th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$60,018
Medicare patients
390
Services billed
1,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban479$467,907
JardianceEmpagliflozin285$264,967
Repatha SureclickEvolocumab113$103,860
XareltoRivaroxaban65$74,472
EntrestoSacubitril/Valsartan61$49,750
FarxigaDapagliflozin Propanediol25$24,786
MultaqDronedarone Hcl22$17,263
NexletolBempedoic Acid19$13,058
Praluent PenAlirocumab12$8,019
Metoprolol Succinate605$7,017
Rosuvastatin Calcium411$5,597
Atorvastatin Calcium514$5,017
Ezetimibe242$4,201
Carvedilol439$3,166
Diltiazem 24hr Er (Cd)Diltiazem Hcl149$3,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$467,907479 claims
Boehringer IngelheimJardiance$81$264,967285 claims
AstraZenecaFarxiga$29$24,78625 claims
Sanofi-aventis U.S. LLCMultaq$18$17,26322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →